Troxacitabina

Troxacitabina Uses, Dosage, Side Effects, Food Interaction and all others data.

Troxacitabina is a nucleoside analog with antineoplastic activity. There has been growing interest in its development for the treatment of patients with refractory lymphoproliferative conditions.

Troxacitabina is a beta-L-nucleoside analog, which has shown preclinical antitumor activity in human xenograft tumor models and antileukemic response in patients with relapsed myeloid leukemia.

Table Of contents

• Troxacitabina
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Troxacitabina
Generic	Troxacitabine
Troxacitabine Other Names	Troxacitabina, Troxacitabine, Troxacitabinum
Type
Formula	C8H11N3O4
Weight	Average: 213.1906 Monoisotopic: 213.074955855
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in leukemia (myeloid).

How Troxacitabina works

Troxacitabina is activated by cellular kinases and incorporated into DNA, inhibiting its replication. In contrast to other cytosine nucleoside analogs, troxacitabine is resistant to inactivation by cytidine deaminase (CD).

Innovators Monograph

You find simplified version here Troxacitabina